- Home
- AAL vs CYTK Comparison
AAL vs CYTK Comparison
Compare AAL & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAL
- CYTK
- Stock Information
- Founded
- AAL 1930
- CYTK 1997
- Country
- AAL United States
- CYTK United States
- Employees
- AAL N/A
- CYTK N/A
- Industry
- AAL Air Freight/Delivery Services
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- AAL Consumer Discretionary
- CYTK Health Care
- Exchange
- AAL Nasdaq
- CYTK Nasdaq
- Market Cap
- AAL 6.9B
- CYTK 5.6B
- IPO Year
- AAL N/A
- CYTK 2004
- Fundamental
- Price
- AAL $11.01
- CYTK $32.17
- Analyst Decision
- AAL Buy
- CYTK Buy
- Analyst Count
- AAL 16
- CYTK 19
- Target Price
- AAL $14.68
- CYTK $77.33
- AVG Volume (30 Days)
- AAL 64.9M
- CYTK 2.4M
- Earning Date
- AAL 04-24-2025
- CYTK 05-06-2025
- Dividend Yield
- AAL N/A
- CYTK N/A
- EPS Growth
- AAL 35.09
- CYTK N/A
- EPS
- AAL 1.02
- CYTK N/A
- Revenue
- AAL $54,192,000,000.00
- CYTK $19,218,000.00
- Revenue This Year
- AAL $4.01
- CYTK $55.84
- Revenue Next Year
- AAL $5.58
- CYTK $646.96
- P/E Ratio
- AAL $10.82
- CYTK N/A
- Revenue Growth
- AAL 1.92
- CYTK 412.21
- 52 Week Low
- AAL $8.50
- CYTK $31.67
- 52 Week High
- AAL $19.10
- CYTK $68.44
- Technical
- Relative Strength Index (RSI)
- AAL 59.85
- CYTK 33.00
- Support Level
- AAL $10.38
- CYTK $31.67
- Resistance Level
- AAL $10.98
- CYTK $43.51
- Average True Range (ATR)
- AAL 0.38
- CYTK 1.93
- MACD
- AAL 0.26
- CYTK -0.70
- Stochastic Oscillator
- AAL 96.83
- CYTK 10.56
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.